BAK1 and cancer: As expected for cancer cells lacking the functional activity of pro-apoptotic (BAX and/or BAK) effectors, BH3 profiling failed to detect an increased overall mitochondrial apoptotic priming in incompetent TIS phenotypes generated in BAX-deficient LoVo colon cancer cells.